Similar articles

• [Arterial hypertension, correlated factors and cardiovascular risk].

  Pessina AC, Casiglia E, Rossi GP, Semplicini A. Pessina AC, et al. Cardiologia. 1991 Dec;36(12 Suppl 1):67-78. Cardiologia. 1991. PMID: 1841807 Review. Italian.
• Arterial hypertension and cardiovascular damage in the elderly: focus on arterial stiffness and left ventricular hypertrophy.

  Paciaroni E, Antonicelli R, Gambini C, Sirolla C. Paciaroni E, et al. Clin Exp Hypertens. 1993;15 Suppl 1:1-7. Clin Exp Hypertens. 1993. PMID: 8513302 Review.
• [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].

  Ibsen H, Pedersen OL, Dahlöf B, Kjeldsen SE, Lindholm LH. Ibsen H, et al. Ugeskr Laeger. 2003 Jan 27;165(5):456-9. Ugeskr Laeger. 2003. PMID: 12599843 Clinical Trial. Danish.
• Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure.

  Mansoor GA, Massie BM. Mansoor GA, et al. Blood Press Monit. 1999;4 Suppl 1:S19-22. Blood Press Monit. 1999. PMID: 10822413 Review.
• Left ventricular hypertrophy: how to influence an important risk factor in hypertension.

  Agabiti-Rosei E, Muiesan ML. Agabiti-Rosei E, et al. J Hypertens Suppl. 1998 Jan;16(1):S53-8. J Hypertens Suppl. 1998. PMID: 9534098 Review.